Technological integration is fundamentally altering clinical standards. Modern surgical suites are increasingly adopting digitally connected platforms and image-guidance systems that enhance procedural accuracy while minimizing infection risks. These innovations, alongside remote surgical assistance, are becoming essential tools for clinicians managing complex cases. Regulatory bodies, including the FDA and the EU MDR, are simultaneously tightening oversight regarding device safety, cybersecurity, and post-market surveillance to keep pace with these digital shifts.

Soft-tissue applications currently dominate the sector, accounting for approximately 42–46% of the market share in 2025. This segment's prevalence is tied to high-volume interventions such as gastrointestinal, gynecological, and cardiovascular surgeries. Meanwhile, the orthopedic segment holds the largest share by procedure type, fueled by an aging global population and the rising incidence of musculoskeletal conditions. North America remains the leading regional market, capturing 40–45% of the total share, followed by Europe, where chronic disease prevalence in countries like Germany and France continues to drive consistent demand for advanced surgical interventions and implants.